Cargando…
Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders
Over the past decade, enormous progress has been made in the field of induced pluripotent stem cells (iPSCs). Patients' somatic cells such as skin fibroblasts or blood cells can be used to generate disease-specific pluripotent stem cells, which have unlimited proliferation and can differentiate...
Autor principal: | Wattanapanitch, Methichit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525795/ https://www.ncbi.nlm.nih.gov/pubmed/31191673 http://dx.doi.org/10.1155/2019/5171032 |
Ejemplares similares
-
Advances in Adoptive Cell Therapy Using Induced Pluripotent Stem Cell-Derived T Cells
por: Netsrithong, Ratchapong, et al.
Publicado: (2021) -
A precise gene delivery approach for human induced pluripotent stem cells using Cas9 RNP complex and recombinant AAV6 donor vectors
por: Chupradit, Koollawat, et al.
Publicado: (2022) -
Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells
por: Netsrithong, Ratchapong, et al.
Publicado: (2020) -
Analysis of Influenza A virus infection in human induced pluripotent stem cells (hiPSCs) and their derivatives
por: Ruangrung, Kanyarat, et al.
Publicado: (2022) -
Dual Small-Molecule Targeting of SMAD Signaling Stimulates Human Induced Pluripotent Stem Cells toward Neural Lineages
por: Wattanapanitch, Methichit, et al.
Publicado: (2014)